Last reviewed · How we verify
NCT00616473
Quality End-of-Life Care in Nursing Homes
trial in Quality of End-of-life Care in Nursing Homes in 7,169 participants. Completed in 1 January 2011.
1 January 2011
Quick facts
| Lead sponsor | University of Nebraska |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 7,169 |
| Start date | 15 December 2006 |
| Primary completion | 1 January 2011 |
| Estimated completion | 1 January 2011 |
| Sites | 1 location across United States |
Conditions studied
- Quality of End-of-life Care in Nursing Homes — all drugs for Quality of End-of-life Care in Nursing Homes →
Sponsor
University of Nebraska
Who can join
19 and older, any sex, with Quality of End-of-life Care in Nursing Homes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine key organizational structures and processes (leadership, teamwork, communication, palliative care) and their impact on the quality of end-of-life care for dying residents and their family members.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00616473
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Nebraska trials
Trials by the same sponsor.
- NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
- NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
- NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
- NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
- NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00616473 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
- Last refreshed: 4 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00616473.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing